Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Endothelin receptor B antagonists decrease glioma cell viability independently of their cognate receptor ; volume:8 ; number:1 ; day:28 ; month:11 ; year:2008 ; pages:1-10 ; date:12.2008
BMC cancer ; 8, Heft 1 (28.11.2008), 1-10, 12.2008
- Creator
-
Montgomery, Jennifer P.
- Contributor
-
Patterson, Paul H.
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-8-354
- URN
-
urn:nbn:de:1111-2016030346180
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Montgomery, Jennifer P.
- Patterson, Paul H.
- SpringerLink (Online service)
Other Objects (12)
Endothelin receptor antagonists : status quo and future perspectives for targeted therapy
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Neurokinin 1 Receptor Antagonists for Pruritus
Irreversible Antagonists for the Adenosine A2B Receptor
Azologization of serotonin 5-HT3 receptor antagonists
Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease
Endothelin receptor antagonists : status quo and future perspectives for targeted therapy
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Neurokinin 1 Receptor Antagonists for Pruritus
Irreversible Antagonists for the Adenosine A2B Receptor
Azologization of serotonin 5-HT3 receptor antagonists
Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists
The Role of Endothelin and Endothelin Antagonists in Chronic Kidney Disease
Endothelin receptor antagonists : status quo and future perspectives for targeted therapy
Leukotriene Receptor Antagonists
Piperazine‐based P2X4 receptor antagonists
Endothelin-receptor antagonists for aneurysmal subarachnoid hemorrhage: an updated meta-analysis of randomized controlled trials
Mineralocorticoid receptor antagonists in dialysis patients
Why are mineralocorticoid receptor antagonists cardioprotective?
Neurokinin 1 Receptor Antagonists for Pruritus
Irreversible Antagonists for the Adenosine A2B Receptor
Azologization of serotonin 5-HT3 receptor antagonists
Idiopathic pre-capillary pulmonary hypertension in patients with end-stage kidney disease: effect of endothelin receptor antagonists
Mineralocorticoid receptor overactivation: targeting systemic impact with non-steroidal mineralocorticoid receptor antagonists